Applications Published 3 January 2001
Published: 25-Aug-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Skin equivalent and method of forming and using same
Board of Trustees of the Leland Stanford Junior University 1063882*Xylitol compsns for treating upper respiratory tract conditions
Jones, Alonzo 1063885*Disninfecting compsn
Bifodan 1063886*P53-dependent secretion of growth inhibitory factors
Quark Biotech 1063887*Novel HIV integrase inhibitors and HIV therapy based in drug combinations including integrase inhibitors
The Regents of the University of California 1063888*Compsns of tetrakis(hydroxymethyl)phosphonium salts with an antifoaming agent
Rhodia Consumer Specialities 1063889*Compsn for deactivating chemically and biologically active agents
Battelle Memorial Institute 1063890*Methods for enhancing antigen presentation on antigen-presenting cells and compsns produced thereby
Genzyme 1-63891*Implantable blood glucose sensor system
Eglise, David 1063916*Method and apparatus for the ear;y diagnosis of subacute, potentially catastrophic illness
The University of Virginia Patent Foundation 1063917*Improved cosmetic formulation and method for amelioration of skin keratoses and striae distensae
Moy, Lawrence 1063962*Improved compsns for inhalation
Glaxo Group 1063958*Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect
Scotia Holdings 1063969*Slow release microcapsules
Aventis Research & Technologies 1063970*Controlled release oral tablet having a unitary core
Andrx Pharmaceuticals 1063971*Polymer based rapidly dissolving tablets and production processes thereof
Yamanouchi Shaklee Pharma 1063972*Biphasic controlled release delivery system for high solubility pharamceuticals and method
Bristol-Myers Squibb 1063973*Analysis of quiescent anticoagulated whole blood samples
Wardlaw, Stephen Clark 1063974*Crosslinkable macromers bearing initiator groups
SurModics 1063975*Starch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
Valtion Teknillinen Tutkimuskeskus 1063976*Coated starch capsules and a process for producing them
Valtion Teknillinen Tutkimuskeskus 1063977*Method of treating neuroma pain
Caldwell Galer 1063978*Methods for decreasing beta amyloid protein production
Children's Medical Centre 1053980*Use of selegiline of desmethylselegiline for treating wounds, burns and dermatological damage
Somerset Pharmaceuticals 1063981*Antagonists for the treatment of CD11/CD18 adhesion receptor mediated disorders
Genentech 1063982*Transdermal therapeutic system (TTS) containing oxybutynin
Schwarz Pharma 1063983*Inflammatory cell inhibitors
British Biotech Pharmaceuticals 1063984*Benzoates derivatives for inhibiting angiogenesis
Biosource Technologies; SRI International 1063985*Compounds and methods for use in treating neoplasia, cancer, hyperproliferative cell growth and chronic inflammatory diseases
Therex Technologies; The Research Foundation of the State University of New York 1063986*Dietary control of arachidonic acid metabolism
Wake Forest University 1063987*Hesperidin and hesperetin as inhibitor of acyl CoA-cholesterol-o-acyl-transferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventative or treating agent for hepatic diseases
Korea Institute of Science and Technology 1063988*Prevention and treatment of adhesions Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk
Onderzoek TNO 1063989*Therapy of oestrogen-associated disorders
Novogen Research 1063990*Statin-matrix metalloproteinase inhibitor combinations
Warner-Lambert 1063991*Sulphurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
Merck 1063992*Paroxetine compsns
SmithKline Beecham 1063993*Method of treating skin irritation
Procter & Gamble 1063994*Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator
Lipha 1063995*Pharmaceutical compsns containing in combination two antagonists selective of arginine-vasopressin V receptors, even of V1A? and V2? receptors
Sanofi-Synthelabo 1063996*Peripheral-type benzodiazepine receptor; a tool for detection, diagnosis, prognosis, and treatment of cancer
Georgetown University Medical Centre 1063997*Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
SW Patentverwertungs 1063998*Epiallopregnanolone in the treatment of CNS disorders
Backstroem, Torbjoern; Wang, Ming-De 1063999*Vitamin D and its analogues in the treatment of tumours and other hyperproliferative disorders
Oregon Health Sciences 1064000*Methods and compsns for treating and preventing mucositis
Mucosal Therapeutics 1064001*Use of sphingosin-1-phosphate, sphingosin-1-phosphate derivatives and/or mixtures thereof for the treatment of inflammatory disorders of the skin
Dermapharm; Schaefer-Korting, Monika; Korting, Hans-Christian; Kleuser, Burkhard 1064002*Neurotrophic properties of IPGS and IPG analogues
Rademacher 1064003*Metal/thiol biocides
Winthrop-University Hospital 1064004*Urokinase plasminogen activator receptor as a target for diagnosis of metastases
Rabbini, Shafaat; Hart, Richard 1064005*Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
University of Medicine and Dentistry of New Jersey 1064006*NRDG
SmithKline Beecham 1064007*Use of at least one protein extract of the Moringa genus plant seeda dn corresponding cosmetic and/or pharmacological compsn
Laboratoires Serobiologiques 1064008*Utilisation of extracts from iris plants, Cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
Bionorica Arzeinmittel 1064009*Peptide compsns and formulation and use of same
Mrs, Llc 1064010*Metastatin and hyalouronate binding proteins and methods of use
EntreMed 1064011*Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding
Biopore 1064012*In vitro formulation of congophilic Maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and prion disease
University of Washington 1064013*Medicament for preventing or treating papilloma virus-specific tumours
MediGene 1064014*Receptor derived peptides as modulators of receptor activity
Receptron 1064015*Compsns for modulating cell differentiation comprising a lipid and a morphogen
Creative Biomolecules 1064016*A method for the prevention of a patient's fibroproliferative vasculopathy
Oy Juvantia Pharma 1064017*Use of isolated domains of Type IV collagen to modify cell and tissue interactions
The Universty of Kansas Medical Centre 1064018*Chemically modified mutant enzymes and methods for producing them and screening them
Genencor International 1064019*Methods for diagnosing and treating autoimmune disease
General Hospital Corp 1064020*Pharmaceutical compsn containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
Senju Pharmaceutical 1064021*HLA-binding peptides and their uses
Epimmune 1064022*Products in the treatment of cancer
Wound Healing of Oklahoma 1064023*Vaccines against circovirus infections
The University of Georgia Research Foundation 1064024*Combined vaccine compsns
SmithKline Beecham Biologicals 1064025*Enhancement of intracellular delivery and tissue targeting of drugs and genes
The Trustees of the University of Pennsylvania 1064026*Apo-2 ligand-anti-her-2-antibody synergism
Genentech 1064027*Disinfecting flat surfaces with form rooms, using water vapour
Keim, Bettina 1064028*Anti-tumour agents
AstraZeneca 1064253*Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
University of Saskatchewan Technologies 1064254*Bicyclo [2.2.1] heptanes and related compounds
Pfizer Products 1064256*Anti-tumour agents
AstraZeneca 1064257*New compounds
AstraZeneca 1064259*Substituted isoindolones and their use as a cyclic GMP modulators in medicaments
Aventis Pharma Deutschland 1064262*Nonnucleoside inhibitors of reverse transcriptase for the treatment of HIV-infection
Parker Hughes Institute 1064263*Cytotoxic metal chelators and methods for making and using same
Wake Forest University 1064264*Synthesis of 3-amino-2-chloro-4-methylpyridine from malonitrile and acetone
Boehringer Ingelheim Pharmaceuticals 1064265*Method for separating an azepine derivative from a mixture containing an amine and an azepine derivative
BASF 1064266*Barbituric acid derivative and preventative and therapeutic agent for bone, and cartilage containing the same
Hoechst Marion Roussel 1064269*Disubstituted pyrazolines and triazolines as Factor XA inhibitors
Du Pont Pharmaceuticals 1064270*Cyclooctadepsipeptides and their use for combating endoparasites
Bayer 1064272*1,3,4-thiadiazoles useful for the treatment of CMV infections
Pharmacia & Upjohn 1064273*Benzenesulphonamide derivatives and their use as medicaments
AstraZeneca 1064274*Process for producing simvaststin and/or its derivatives
Synthon 1064275*Substituted bisindolylmaleimides for the inhibition of cell proliferation
F Hoffmann-La Roche 1064279*Acroloyl derivatives analoguous to distamycin, process for preparing them and their use as antitumour agents
Pharmacia & Upjohn 1064280*Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumour agents
Pharmacia & Upjohn 1064281*Crystalline form of aroxetine
SmithKline Beecham 1064282*Pyrazolo-pyridine derivatives as ligands for GABA receptors
Merck Sharp & Dohme 1064283*Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products
Macef 1064294*Novel cephalotaxane derivatives and process for their preparation
Oncopharm 1064285*Synthesis of aryl boronic acids
Boulder Scientific Company 1064286*Heterocyclic signal transduction inhibitors, compsns containing them
Ariad Pharmaceuticals 1064289*Method of synthesising GM3
Ludwig Institute for Cancer Research 1064291*Photoactivatable nucleic acid derivatives
SurModics 1064292*Crystallisation of lactitol, crystalline lactitol product and use thereof
Xyrofin 1064293*5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them
GEM Pharmaceuticals 1064294*Methods and compsns for diagnosing and treating chromosome-18P related disorders
Millennium Pharmaceuticals 1064295*Thermostable DNA polymerase from Thermoanaerobacter thermohydrosulphuricus
Amersham Pharmacia Biotech 1064296*95 secreted human proteins
Human Genome Sciences 1064297*Inhibitors of caspases
Vertex Pharmaceuticals 1064298*Peptide turn mimetics
The University of Queensland 1064300*Bacterial yael family members as targets for antimicrobial drug design
Glaxo Group 1064301*Secreted proteins and polynucleotides encoding them
Genetics Institute 1064302*Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
NorthWest Biotherapeutics 1064303* Methods for identifying inducers and inhibitors of proteolytic antibodies, compsns and their uses
University of Nebraska Board of Regents 1064308*Epitopes in viral envelope proteins and specific antibodies directed against these epitopes; use for detection of HCV viral antigen in host tissue
Innogenetics 1064309*
